# [18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

> **NCT00323076** · PHASE1,PHASE2 · TERMINATED · sponsor: **AHS Cancer Control Alberta** · enrollment: 92 (actual)

## Conditions studied

- Renal Cell Carcinoma
- Neuroendocrine Tumours

## Interventions

- **DRUG:** 18F-FAZA PET Imaging

## Key facts

- **NCT ID:** NCT00323076
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09-12
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-02-04
- **Target enrollment:** 92 (ACTUAL)
- **Why stopped:** Retirement of former Qualified Investigator and lack of resources to complete study.
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00323076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00323076, "[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00323076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*